Abstract
Ketamine acts mainly as a N-methyl-D-aspartate receptor (NMDAr) antagonist. Originally developed as a general anesthetic, it is now seldom employed as such in richer countries due to the relatively high risk of psychotomimetic adverse effects. Recently, low – dose regimens in the range of 0.25 – 0.5 mg/kg as an initial bolus followed by 50 – 500 μg/kg/h have been proposed as an adjuvant for postoperative analgesia and for the reduction of exogenous opioid – induced hyperalgesia. In this review, we examine the evidence for clinical usefulness of perioperative ketamine infusion and its role in the context of general and/or regional anesthesia.
Keywords: Ketamine, analgesia, perioperative care, pain, postoperative, analgesics, non-narcotic
Current Drug Targets
Title: Clinical Uses of Low – Dose Ketamine in Patients Undergoing Surgery
Volume: 10 Issue: 8
Author(s): M. Berti, M. Baciarello, R. Troglio and G. Fanelli
Affiliation:
Keywords: Ketamine, analgesia, perioperative care, pain, postoperative, analgesics, non-narcotic
Abstract: Ketamine acts mainly as a N-methyl-D-aspartate receptor (NMDAr) antagonist. Originally developed as a general anesthetic, it is now seldom employed as such in richer countries due to the relatively high risk of psychotomimetic adverse effects. Recently, low – dose regimens in the range of 0.25 – 0.5 mg/kg as an initial bolus followed by 50 – 500 μg/kg/h have been proposed as an adjuvant for postoperative analgesia and for the reduction of exogenous opioid – induced hyperalgesia. In this review, we examine the evidence for clinical usefulness of perioperative ketamine infusion and its role in the context of general and/or regional anesthesia.
Export Options
About this article
Cite this article as:
Berti M., Baciarello M., Troglio R. and Fanelli G., Clinical Uses of Low – Dose Ketamine in Patients Undergoing Surgery, Current Drug Targets 2009; 10 (8) . https://dx.doi.org/10.2174/138945009788982496
DOI https://dx.doi.org/10.2174/138945009788982496 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Therapeutic Perspectives in the Antiphospholipid Syndrome
Current Rheumatology Reviews Neuroprotection and Hypothermia in Infants and Children
Current Drug Targets Hormones and the Autonomic Nervous System are Involved in Suprachiasmatic Nucleus Modulation of Glucose Homeostasis
Current Diabetes Reviews Virus Vasculopathy and Stroke: An Under-Recognized Cause and Treatment Target
Infectious Disorders - Drug Targets Inflammation in Ischemic Stroke: Mechanisms, Consequences and Possible Drug Targets
CNS & Neurological Disorders - Drug Targets The GH/IGF-1 Axis in Chronic Heart Failure
Endocrine, Metabolic & Immune Disorders - Drug Targets Biochemical Markers for Brain Injury Monitoring in Children with or without Congenital Heart Diseases
CNS & Neurological Disorders - Drug Targets Challenges and Perspectives of Antiplatelet Therapy in Patients with Diabetes Mellitus and Coronary Artery Disease
Current Pharmaceutical Design Antithrombotic Therapy in Cardiac Embolism
Current Cardiology Reviews Bevacizumab for Malignant Brain Gliomas. Which is the Current Evidence?
Recent Patents on Inflammation & Allergy Drug Discovery Management of Hypertension in Relation to Acute Coronary Syndromes and Revascularisation
Current Pharmaceutical Design Headache, Outpatient Management and Referral to Specialty Clinics, Clinical Audit
New Emirates Medical Journal Iatrogenic Right Atrial Thrombus Complicated by Pulmonary Embolism: Management and Outcomes
Current Cardiology Reviews Fibrinogen: A Predictor of Vascular Disease
Current Pharmaceutical Design Antithrombotic Treatment Management in Patients with Intracerebral Hemorrhage: Reversal and Restart
Current Pharmaceutical Design Inhibitors of Nitric Oxide Synthase: What's up and What's Next?
Current Enzyme Inhibition New Perspectives in Glioma Immunotherapy
Current Pharmaceutical Design Cerebral Amyloid Angiopathy-related Intracerebral Hemorrhage Score For Predicting Outcome
Current Neurovascular Research Update on Medical and Surgical Management of Intracerebral Hemorrhage
Reviews on Recent Clinical Trials Long-Term Safety and Efficacy of Bapineuzumab in Patients with Mild-to-Moderate Alzheimer’s Disease: A Phase 2, Open-Label Extension Study
Current Alzheimer Research